Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Andrew Thamboo is a prominent Canadian rhinologist, skull base surgeon, and translational researcher based in Vancouver, British Columbia. He serves as the Research Director of the St. Paul's Sinus Centre and is a Principal Investigator at the Centre for Heart Lung Innovation (HLI). His research focuses on the "unified airway hypothesis," upper airway physiology, and personalized medicine for chronic sinus disease and sinonasal tumors. Dr. Thamboo is a key innovator behind SinuStim, a medical device designed to alleviate nasal congestion through electrical nerve stimulation. Additionally, he leads clinical trials investigating the immunologic impact of biologics, such as dupilumab, in patients with asthma and chronic rhinosinusitis. He is recognized as a national and international leader in rhinology and skull base surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Andrew Thamboo.